Meridian Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Meridian Wealth Partners's LLY Position: Q1 2026 in Review
Meridian Wealth Partners increased its Eli Lilly (LLY) stake by 2.9% in Q1 2026, buying an estimated $16.2K and bringing the position to 576 shares worth $529K. The position accounts for 0.07% of the portfolio, ranked #65.
Meridian Wealth Partners first reported a position in LLY in Q4 2019 and has held it in 18 quarters since. The position peaked at $613K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Meridian Wealth Partners held 576 shares of Eli Lilly worth $529K as of Q1 2026.
- Meridian Wealth Partners bought 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
- Eli Lilly made up 0.07% of Meridian Wealth Partners's portfolio in Q1 2026, its #65 holding.
- Meridian Wealth Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 18 quarters since.
- Meridian Wealth Partners's Eli Lilly position peaked at $613K in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Meridian Wealth Partners's 13F filing for Q1 2026, filed 14 May 2026.